Has Lyuba Belitsky, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,504 in general payments to Lyuba Belitsky, MD across 592 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lyuba Belitsky, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lyuba Belitsky, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lyuba Belitsky, MD

Endocrinology, Diabetes & Metabolism · Chandler, AZNPI 1205936143

Payments from drug & device makers

$10,504in general payments, 2019–2025

Across 592 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$1K
AstraZeneca$1K
Novo Nordisk$963
Boehringer Ingelheim$737
Amgen$734
Abbott$531
plus $5K from 52 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	72	$1,290
AstraZeneca(2 entities)	47	$1,009
Novo Nordisk	65	$963
Boehringer Ingelheim	49	$737
Amgen(2 entities)	31	$734
Abbott	33	$531
Xeris Pharmaceuticals, Inc.	32	$530
Sanofi-aventis U.S. LLC	29	$493
AbbVie	24	$391
Insulet Corporation	18	$383
Mannkind Corporation	24	$328
Radius Health, Inc.	16	$321
Amneal Pharmaceuticals LLC	17	$256
Antares Pharma, Inc.	13	$215
Johnson & Johnson	11	$151
Corcept Therapeutics	8	$139
Bayer	7	$132
Ultragenyx Pharmaceutical Inc.	5	$120
Neurocrine Biosciences, Inc.	4	$118
Ascendis Pharma Endocrinology Inc	5	$97
Sanofi	1	$90
Merck	7	$86
Recordati_rare_diseases_inc.	4	$80
Dexcom, Inc.	4	$75
Esperion Therapeutics, Inc.	4	$75
Astellas Pharma US Inc	4	$72
Medtronic	4	$65
Tandem Diabetes Care, Inc.	3	$58
Cequr Corporation	2	$58
Rhythm Pharmaceuticals, Inc.	3	$54
Alfasigma USA, Inc.	3	$53
Shire North American Group Inc	3	$51
Companion Medical, Inc.	3	$50
IBSA Pharma Inc.	3	$48
Tolmar, Inc.	3	$48
Topcon Healthcare Solutions, Inc.	1	$43
Vistapharm, Inc.	3	$43
Intuity Medical Inc	2	$41
Sequel Med Tech, LLC	2	$38
Madrigal Pharmaceuticals	1	$38
Verity Pharmaceuticals Inc.	2	$37
Acerus Pharmaceuticals Corporation	2	$33
Acella Pharmaceuticals, LLC	2	$32
BD	1	$28
Echosens North America, Inc.	2	$23
Nevro Corp.	1	$23
UCB, Inc.	1	$23
Valeritas, Inc.	1	$23
Dermira, Inc.	1	$22
Lifescan, Inc.	1	$21
Amphastar Pharmaceuticals, Inc.	1	$20
Ascensia Diabetes Care US Inc.	1	$19
Halozyme Inc	1	$19
Novartis	1	$18
Aytu Biopharma, Inc.	1	$17
BETA Bionics, Inc.	1	$16
Amryt Pharma Holdings Ltd	1	$14
Ipsen Biopharmaceuticals, Inc	1	$13

How this compares

$10,504 in reported general payments places this provider in the 75th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.

See all endocrinology, diabetes & metabolism providers in Arizona →

Medicare billing

Part B allowed, 2024

$145,453

Medicare patients

270

Services billed

1,271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Chandler

Seema AhluwaliaChandler$16K
Naga Nalini TirumalasettyChandler$8K
Kevin YuenPhoenix$733K
Muhammad SethiTucson$670K
Amir HarariScottsdale$361K
Joan BaileyPhoenix$316K
Kristina BlohmScottsdale$220K
Karen HerbstTucson$200K
Peter ReavenPhoenix$142K
Laura KnechtCave Creek$142K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →